Literature DB >> 11782318

An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development.

Richard A Klinghoffer1, T Guy Hamilton, Renée Hoch, Philippe Soriano.   

Abstract

A central issue in signal transduction is the physiological contribution of different growth factor-initiated signaling pathways. We have generated knockin mice harboring mutations in the PDGFalpha receptor (PDGFalphaR) that selectively eliminate its capacity to activate PI3 kinase (alpha(PI3K)) or Src family kinases (alpha(Src)). The alpha(PI3K) mutation leads to neonatal lethality due to impaired signaling in many cell types, but the alpha(Src) mutation only affects oligodendrocyte development. A third knockin line containing mutations that eliminate multiple docking sites does not increase the severity of the alpha(PI3K) mutation. However, embryos with mutations in the PI3K binding sites of both PDGFRs (alpha and beta) recapitulate the PDGFalphaR null phenotype. Our results indicate that PI3K has a predominant role in PDGFalphaR signaling in vivo and that RTK-activated signaling pathways execute both specific and overlapping functions during mammalian development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782318     DOI: 10.1016/s1534-5807(01)00103-4

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  84 in total

1.  Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.

Authors:  Sachiko Ohshima-Hosoyama; Monika A Davare; Suresh I Prajapati; Jinu Abraham; Sangeet Lal; Laura D Nelon; Aoife Kilcoyne; Francis J Giles; Martha A Hanes; Brian P Rubin; Charles Keller
Journal:  J Pediatr Hematol Oncol       Date:  2012-03       Impact factor: 1.289

Review 2.  PDGF function in diverse neural crest cell populations.

Authors:  Christopher L Smith; Michelle D Tallquist
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

3.  The receptor tyrosine kinase Pvr promotes tissue closure by coordinating corpse removal and epidermal zippering.

Authors:  Rebecca A Garlena; Ashley L Lennox; Lewis R Baker; Trish E Parsons; Seth M Weinberg; Beth E Stronach
Journal:  Development       Date:  2015-08-20       Impact factor: 6.868

4.  Regulation of fibroblast lipid storage and myofibroblast phenotypes during alveolar septation in mice.

Authors:  Stephen E McGowan; Diann M McCoy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-22       Impact factor: 5.464

5.  Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.

Authors:  Youzhou Sang; Yanli Hou; Rongrong Cheng; Liang Zheng; Angel A Alvarez; Bo Hu; Shi-Yuan Cheng; Weiwei Zhang; Yanxin Li; Haizhong Feng
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 6.  Cilia and developmental signaling.

Authors:  Jonathan T Eggenschwiler; Kathryn V Anderson
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 7.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

8.  Fibroblast growth factor receptor-Frs2α signaling is critical for nephron progenitors.

Authors:  Valeria Di Giovanni; Kenneth A Walker; Daniel Bushnell; Caitlin Schaefer; Sunder Sims-Lucas; Pawan Puri; Carlton M Bates
Journal:  Dev Biol       Date:  2015-01-30       Impact factor: 3.582

9.  Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors.

Authors:  Masahiro Shin; Ira Male; Timothy J Beane; Jacques A Villefranc; Fatma O Kok; Lihua J Zhu; Nathan D Lawson
Journal:  Development       Date:  2016-09-12       Impact factor: 6.868

Review 10.  Gene-environment interactions in development and disease.

Authors:  C Lovely; Mindy Rampersad; Yohaan Fernandes; Johann Eberhart
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-09-14       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.